Insights

Innovative Delivery Platform Clearside Biomedical’s proprietary SCS Microinjector offers a unique, non-surgical method for targeted eye therapy delivery, presenting opportunities to partner with ophthalmic companies seeking novel drug delivery solutions for back-of-the-eye treatments.

Expanding Product Pipeline With ongoing development of small molecule candidates and a focus on suprachoroidal delivery, there is potential to commercialize new therapies and attract collaborations with pharmaceutical companies aiming to enhance their ophthalmic portfolios.

Recent Industry Engagements Active participation in prominent conferences like EURETINA and ARVO indicates strong industry visibility and networking potential, providing avenues to introduce products to key ophthalmology stakeholders and thought leaders.

Strategic Partnerships Clearside’s approach of partnering its delivery platform with other therapeutic innovators opens avenues for joint ventures, licensing, or co-development deals that can accelerate market penetration and technology adoption.

Targeted Market Segment With FDA approval of its first product, XIPERE, the company is positioned within a niche but growing treatment segment for sight-threatening eye conditions, offering sales opportunities with eye care providers and specialty clinics seeking advanced therapeutics.

Clearside Biomedical, Inc. Tech Stack

Clearside Biomedical, Inc. uses 8 technology products and services including Backbone.js, jQuery, Web Vitals, and more. Explore Clearside Biomedical, Inc.'s tech stack below.

  • Backbone.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Web Vitals
    Javascript Libraries
  • Microsoft Azure
    Platform As A Service
  • Akamai Bot Manager
    Security
  • Akamai Web Application Protector
    Security
  • Bootstrap
    UI Frameworks
  • Contact Form 7
    Web Platform Extensions

Media & News

Clearside Biomedical, Inc.'s Email Address Formats

Clearside Biomedical, Inc. uses at least 1 format(s):
Clearside Biomedical, Inc. Email FormatsExamplePercentage
First.Last@clearsidebio.comJohn.Doe@clearsidebio.com
92%
LastF@clearsidebio.comDoeJ@clearsidebio.com
3%
Last@clearsidebio.comDoe@clearsidebio.com
3%
FirstLa@clearsidebio.comJohnDo@clearsidebio.com
2%

Frequently Asked Questions

Where is Clearside Biomedical, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc.'s main headquarters is located at 900 North Point Parkway, Suite 200. The company has employees across 2 continents, including North AmericaEurope.

What is Clearside Biomedical, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Clearside Biomedical, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Clearside Biomedical, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc.'s official website is clearsidebio.com and has social profiles on LinkedInCrunchbase.

How much revenue does Clearside Biomedical, Inc. generate?

Minus sign iconPlus sign icon
As of December 2025, Clearside Biomedical, Inc.'s annual revenue is estimated to be $5.8M.

What is Clearside Biomedical, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Clearside Biomedical, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Clearside Biomedical, Inc. has approximately 36 employees across 2 continents, including North AmericaEurope. Key team members include Cfo: C. D.Chief Clinical Officer: S. C.Vice President Supply Chain: T. C.. Explore Clearside Biomedical, Inc.'s employee directory with LeadIQ.

What industry does Clearside Biomedical, Inc. belong to?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc. operates in the Biotechnology Research industry.

What technology does Clearside Biomedical, Inc. use?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc.'s tech stack includes Backbone.jsjQueryWeb VitalsMicrosoft AzureAkamai Bot ManagerAkamai Web Application ProtectorBootstrapContact Form 7.

What is Clearside Biomedical, Inc.'s email format?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc.'s email format typically follows the pattern of First.Last@clearsidebio.com. Find more Clearside Biomedical, Inc. email formats with LeadIQ.

How much funding has Clearside Biomedical, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Clearside Biomedical, Inc. has raised $7.9M in funding. The last funding round occurred on Mar 05, 2013 for $7.9M.

When was Clearside Biomedical, Inc. founded?

Minus sign iconPlus sign icon
Clearside Biomedical, Inc. was founded in 2012.

Clearside Biomedical, Inc.

Biotechnology ResearchGeorgia, United States11-50 Employees

Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). Clearside’s SCS injection platform, utilizing the Company’s proprietary SCS Microinjector®, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector and strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. Clearside’s first product, XIPERE™ (triamcinolone acetonide injectable suspension) for suprachoroidal use, was approved by the U.S. Food and Drug Administration in October 2021.

Section iconCompany Overview

Headquarters
900 North Point Parkway, Suite 200
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $7.9M

    Clearside Biomedical, Inc. has raised a total of $7.9M of funding over 1 rounds. Their latest funding round was raised on Mar 05, 2013 in the amount of $7.9Mas a venture capital.

  • $1M$10M

    Clearside Biomedical, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $7.9M

    Clearside Biomedical, Inc. has raised a total of $7.9M of funding over 1 rounds. Their latest funding round was raised on Mar 05, 2013 in the amount of $7.9Mas a venture capital.

  • $1M$10M

    Clearside Biomedical, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.